About Us

Apitope Technology (Bristol) Ltd (Apitope, the Company) is a biopharmaceutical company with world leading research and development in the treatment of allergy and autoimmune diseases. Apitope is developing novel therapeutic peptide vaccines that represent major advances in therapy and address critical unmet needs. Apitope has an impressive record of commercial and technical achievement since its founding at the University of Bristol in 2002 and has built an exciting and innovative product portfolio.

With 15 years of world-class research, Apitope is a leader in therapeutic vaccine R&D.